Witkowski is an associate professor of surgery and director of the Pancreatic and Islet Transplant Program at The University of Chicago. He is a leader of the Islets for US Collaborative and member of the Pancreas and Islet Transplantation Committee at the United Network for Organ Sharing.
On April 15, an FDA advisory committee concluded that the islet cell therapy donislecel demonstrated a favorable risk-benefit profile for certain patients with difficult-to-control type 1 diabetes.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.